Anatomical pathology solutions provider Leica Biosystems is to acquire Aperio, a provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, which is headquartered in is ...
NEW YORK & VISTA, Calif.--(BUSINESS WIRE)--Paige, a global leader in AI-based digital diagnostics, and Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today ...
Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of the ProximityScope™ assay, a groundbreaking spatial ...
SHELTON, Connecticut, Dec. 2, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) and Leica Biosystems announce collaboration for an integrated ...
Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD's RNAscope in situ ...
Leica Biosystems, a global leader in workflow solutions and automation is excited to host Multiplex User Meeting, February 2-3, 2021. Starting at 9:00am CET on February 2, and 9:00am SST on February 3 ...
MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell ...
Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to ...
Leica Biosystems has announced an affiliate has agreed to acquire Aperio, according to a news release. Aperio is a provider of ePathology solutions based in Vista, Calif. Following the acquisition, ...
LOS ANGELES--(BUSINESS WIRE)--Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results